(Q50515474)

14 March 2018

title

Interleukin-33 prolongs allograft survival during chronic cardiac rejection. (English)

1 reference

14 March 2018

0 references

5

Edward K Geissler

1 reference

14 March 2018

author name string

Stefan M Brunner

1

1 reference

14 March 2018

Gabriela Schiechl

2

1 reference

14 March 2018

Werner Falk

3

1 reference

14 March 2018

Hans J Schlitt

4

1 reference

14 March 2018

Stefan Fichtner-Feigl

6

1 reference

14 March 2018

publication date

28 July 2011

1 reference

14 March 2018

published in

Transplant International

1 reference

14 March 2018

volume

24

1 reference

14 March 2018

issue

10

1 reference

14 March 2018

page(s)

1027-1039

1 reference

14 March 2018

The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

Disease-associated functions of IL-33: the new kid in the IL-1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

IL-33 reduces the development of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

IL-33 reduces macrophage foam cell formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

The IL-33/ST2 pathway: therapeutic target and novel biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

Cytokines Regulate the Pattern of Rejection and Susceptibility to Cyclosporine Therapy in Different Mouse Recipient Strains After Cardiac Allografting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

Potential T regulatory cell therapy in transplantation: how far have we come and how far can we go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

TGF-beta, IL-6, IL-17 and CTGF direct multiple pathologies of chronic cardiac allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

Administration of anti-interleukin-6 monoclonal antibody prolongs cardiac allograft survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

How are T(H)2-type immune responses initiated and amplified?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

IL-13 prolongs allograft survival: association with inhibition of macrophage cytokine activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

IL-33 prolongs murine cardiac allograft survival through induction of TH2-type immune deviation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

Regulatory T cells are critical to tolerance induction in presensitized mouse transplant recipients through targeting memory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

Prevention of allograft rejection by amplification of Foxp3(+)CD4(+)CD25(+) regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

IL-33 promotes DC development in BM culture by triggering GM-CSF production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

Subsets, expansion and activation of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

Myeloid-derived suppressor cell heterogeneity and subset definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

Mechanism of T cell tolerance induced by myeloid-derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

Myeloid-derived suppressor cells: natural regulators for transplant tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

Tolerogenic dendritic cells and myeloid-derived suppressor cells: potential for regulation and therapy of liver auto- and alloimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2011.01306.X

10.1111/J.1432-2277.2011.01306.X

21 January 2018

Identifiers

DOI

1 reference

14 March 2018

release_kvcinx5lknflbdiel4oj6wtthe

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kvcinx5lknflbdiel4oj6wtthe

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

21797940

1 reference

14 March 2018